SNES vs. NITO, BSLK, EVGN, GURE, DNMR, CNEY, TANH, GAMCW, LNZAW, and ORGNW
Should you be buying SenesTech stock or one of its competitors? The main competitors of SenesTech include N2OFF (NITO), Bolt Projects (BSLK), Evogene (EVGN), Gulf Resources (GURE), Danimer Scientific (DNMR), CN Energy Group. (CNEY), Tantech (TANH), Golden Arrow Merger (GAMCW), LanzaTech Global (LNZAW), and Origin Materials (ORGNW). These companies are all part of the "chemicals" industry.
SenesTech vs.
SenesTech (NASDAQ:SNES) and N2OFF (NASDAQ:NITO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings, valuation and community ranking.
N2OFF has lower revenue, but higher earnings than SenesTech.
SenesTech received 322 more outperform votes than N2OFF when rated by MarketBeat users.
In the previous week, SenesTech had 2 more articles in the media than N2OFF. MarketBeat recorded 4 mentions for SenesTech and 2 mentions for N2OFF. SenesTech's average media sentiment score of 0.05 beat N2OFF's score of 0.00 indicating that SenesTech is being referred to more favorably in the media.
SenesTech has a beta of 0.36, meaning that its share price is 64% less volatile than the S&P 500. Comparatively, N2OFF has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.
5.2% of SenesTech shares are owned by institutional investors. Comparatively, 61.2% of N2OFF shares are owned by institutional investors. 10.0% of SenesTech shares are owned by insiders. Comparatively, 8.2% of N2OFF shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
SenesTech has a net margin of -403.51% compared to N2OFF's net margin of -3,165.66%. N2OFF's return on equity of -96.06% beat SenesTech's return on equity.
SenesTech presently has a consensus price target of $10.00, indicating a potential upside of 230.03%. Given SenesTech's stronger consensus rating and higher probable upside, equities research analysts clearly believe SenesTech is more favorable than N2OFF.
Summary
SenesTech beats N2OFF on 9 of the 15 factors compared between the two stocks.
Get SenesTech News Delivered to You Automatically
Sign up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
SenesTech Competitors List
Related Companies and Tools
This page (NASDAQ:SNES) was last updated on 2/22/2025 by MarketBeat.com Staff